Bioniq

Bioniq operates on a direct-to-consumer subscription model, serving health-conscious individuals, wellness enthusiasts, and athletes. The company's business model is built around two core products: Bioniq PRO and Bioniq GO. Bioniq PRO, the premium service, utilizes comprehensive blood test results to analyze over 50 biomarkers, which are then processed by a proprietary AI algorithm to create a precise, customized supplement formula. The Bioniq GO service offers a more accessible option, using an extensive online questionnaire to predict nutrient needs and generate a personalized formula. Both products are delivered as patented slow-release granules, designed for enhanced absorption compared to traditional pills. The company has built a proprietary database of over six million biochemical data points from more than 100,000 members to refine its algorithm.

The company has raised a total of $31.1 million over several funding rounds, with significant investments from firms like HV Capital and Unbound. It gained notable attention with investments from high-profile athletes like Cristiano Ronaldo, who is also a long-time user of the product, and Diogo Dalot. Bioniq has expanded its global footprint, with a significant customer base in the United States and a presence in over 60 countries. Strategic partnerships with diagnostic labs and acquisitions of companies like VAHA and LOEWI have further strengthened its market position.